Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ameenathul Mazaya Fawzy"'
Autor:
Giulio Francesco Romiti, Marco Proietti, Marco Vitolo, Niccolò Bonini, Ameenathul Mazaya Fawzy, Wern Yew Ding, Laurent Fauchier, Francisco Marin, Michael Nabauer, Gheorghe Andrei Dan, Tatjana S. Potpara, Giuseppe Boriani, Gregory Y. H. Lip, on behalf of the ESC-EHRA EORP-AF General Long-Term Registry Investigators
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Clinical complexity is increasingly prevalent among patients with atrial fibrillation (AF). The ‘Atrial fibrillation Better Care’ (ABC) pathway approach has been proposed to streamline a more holistic and integrated approach t
Externí odkaz:
https://doaj.org/article/a8f47e6d20f141bcb20d1cde473a30a1
Publikováno v:
Fawzy, A M, Rivera-Caravaca, J M, Fauchier, L & Lip, G Y H 2023, ' Response to letter from Du et al regarding article "Sodium-glucose cotransporter-2 inhibitor use was associated with lower risks of stroke and cardiac arrest but not ventricular arrhythmias?" ', Diabetes, Obesity and Metabolism, vol. 25, no. 2, pp. 630-633 . https://doi.org/10.1111/dom.14913
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bf001b460dac1dc7fc6787d10e73d86
https://doi.org/10.1111/dom.14913
https://doi.org/10.1111/dom.14913
Autor:
Ameenathul Mazaya Fawzy, José Miguel Rivera‐Caravaca, Paula Underhill, Laurent Fauchier, Gregory Y. H. Lip
Publikováno v:
Fawzy, A M, Rivera-Caravaca, J M, Underhill, P, Fauchier, L & Lip, G Y H 2023, ' Incident heart failure, arrhythmias and cardiovascular outcomes with sodium-glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes : Insights from a global federated electronic medical record database ', Diabetes, Obesity and Metabolism, vol. 25, no. 2, pp. 602-610 . https://doi.org/10.1111/dom.14854
AIM: To investigate the impact of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the risk of incident heart failure and adverse cardiovascular outcomes.METHODS: All patients with diabetes who were registered between January 2018 and December 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afdc66a0d524f1a666d20a48096304d
https://doi.org/10.1111/dom.14854
https://doi.org/10.1111/dom.14854
Autor:
Wern Yew Ding, Marco Proietti, Giulio Francesco Romiti, Marco Vitolo, Ameenathul Mazaya Fawzy, Giuseppe Boriani, Francisco Marin, Carina Blomström-Lundqvist, Tatjana S. Potpara, Laurent Fauchier, Gregory Y. H Lip
Publikováno v:
Ding, W Y, Proietti, M, Romiti, G F, Vitolo, M, Fawzy, A M, Boriani, G, Marin, F, Blomström-Lundqvist, C, Potpara, T S, Fauchier, L, Lip, G Y H & ESC-EHRA EORP-AF Long-Term General Registry Investigators 2023, ' Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation : A report from the ESC-EHRA EORP-AF long-term general registry ', European Journal of Internal Medicine, vol. 107, pp. 60-65 . https://doi.org/10.1016/j.ejim.2022.11.004
Background: Effects of Atrial Fibrillation Better Care (ABC) adherence among high-risk atrial fibrillation (AF) subgroups remains unknown. We aimed to evaluate the impact of ABC adherence on clinical outcomes in these high-risk patients. Methods: EOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f02f9a860307fa1ba60631945c775c6
https://pubmed.ncbi.nlm.nih.gov/36372692
https://pubmed.ncbi.nlm.nih.gov/36372692